GlassScriptPhysician profile
Yi C Hsieh
NPI 1184628661
$9,930.04
in general payments reported to CMS, 2019-2025
48 companies · $1,744 in 2025
The $1,744 reported for 2025 was more than what 77% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,632 · 2020: $355 · 2021: $739 · 2022: $1,194 · 2023: $2,256 · 2024: $2,009 · 2025: $1,744.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,522 · Consulting Fee: $1,050 · Education: $438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,521.74 |
| Consulting Fee | $1,050.00 |
| Education | $437.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,893.24 | 2019-2025 | Xtandi, Myrbetriq |
| Verathon INC. | $1,050.00 | 2023-2025 | Npd Clinical Study |
| Dendreon Pharmaceuticals LLC | $950.39 | 2020-2025 | Provenge |
| Janssen Biotech, INC. | $502.35 | 2019-2025 | Erleada, Akeega, Balversa |
| Sumitomo Pharma America, INC. | $423.97 | 2023-2025 | Orgovyx, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $411.67 | 2019-2024 | |
| Pfizer INC. | $382.99 | 2019-2025 | |
| Coloplast Corp | $375.80 | 2019-2024 | Porges Coloplast |
| Myriad Genetic Laboratories, INC. | $372.89 | 2021-2025 | Prolaris |
| Boston Scientific Corporation | $328.23 | 2019-2024 | Advantage System, Lithovue |
| Abbvie INC. | $313.17 | 2019-2025 | |
| Antares Pharma, INC. | $216.89 | 2019-2025 | Xyosted |
| Merck Sharp & Dohme LLC | $196.17 | 2021-2025 | Lynparza, Keytruda, Welireg |
| Accord Healthcare, INC. | $189.23 | 2023-2025 | |
| Urogen Pharma, INC. | $183.23 | 2021-2025 | Jelmyto |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $168.53 | 2019-2025 | Adstiladrin |
| Convatec INC. | $152.87 | 2021-2025 | |
| Progenics Pharmaceuticals, INC. | $146.24 | 2021-2025 | Pylarify |
| Immunitybio, INC. | $126.09 | 2024-2025 | |
| Endo Pharmaceuticals INC. | $121.99 | 2019-2024 | Xiaflex |
| Blue Earth Diagnostics | $119.95 | 2024-2025 | Posluma |
| Myovant Sciences INC. | $100.76 | 2021-2022 | |
| Comsort, INC | $100.00 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $98.10 | 2021-2022 | |
| 180 Medical, INC. | $98.09 | 2022-2025 | Cure Ultra Catheter |
| Novartis Pharmaceuticals Corporation | $86.13 | 2023-2025 | |
| Urovant Sciences INC | $82.42 | 2022 | |
| Sun Pharmaceutical Industries INC. | $76.19 | 2022-2023 | Yonsa |
| Endo USA, INC. | $62.87 | 2024-2025 | Xiaflex, Aveed |
| Astrazeneca Pharmaceuticals LP | $61.89 | 2022-2023 | Faslodex |
| Amgen INC. | $56.84 | 2021-2023 | Xgeva |
| Therapeuticsmd, INC. | $55.80 | 2019-2020 | |
| C. R. Bard, INC. & Subsidiaries | $46.71 | 2019 | |
| Hollister Incorporated | $41.32 | 2022-2023 | Vapro Pocket |
| Olympus America INC. | $35.46 | 2023-2025 | Itind System |
| Procept Biorobotics Corporation | $34.94 | 2025 | |
| Teleflex LLC | $30.73 | 2025 | Deknatel |
| Angiodynamics, INC. | $30.35 | 2024 | Nanoknife |
| Telix Pharmaceuticals | $28.75 | 2023 | Illuccix |
| Baxter Healthcare | $25.43 | 2025 | Tisseel |
| Laborie Medical Technologies Corp. | $21.47 | 2023 | |
| Tolmar, INC. | $20.95 | 2023 | |
| Palette Life Sciences, INC. | $20.45 | 2023 | |
| Smith+Nephew, INC. | $18.47 | 2022 | |
| Karl Storz Endoscopy-America | $18.45 | 2025 | N.A. |
| Agiliti Surgical, INC. | $18.41 | 2024 | Sonablate Hifu |
| Cook Medical LLC | $17.53 | 2019 | |
| Profound Medical Corp. | $15.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yi Hsieh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.